TP53 and cancer: One of thehypotheses to explain why this deleterious mutation has persisted is based on itsrelatively reduced penetrance, which confers a tumor risk of 30% before the age of 30,while lifetime cancer risk is similar to other TP53 mutations (Garritano et al., 2010).